APPLICATION
ANDA077923
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MELOXICAMDiscontinued
MELOXICAM 15MG · TABLET · ORAL
MELOXICAMDiscontinued
MELOXICAM 7.5MG · TABLET · ORAL
Approval history
2024-11-21Labeling · Supplement 13 · standardAP
2023-01-05Labeling · Supplement 11 · standardAP
2016-09-08Labeling · Supplement 9 · standardAP
2016-09-08Labeling · Supplement 7 · standardAP
2016-09-08Labeling · Supplement 10 · standardAP
2013-06-12Labeling · Supplement 5 · standardAP
2009-09-04Labeling · Supplement 4AP
2008-02-21Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.